# Apotex Inc. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/apotex-inc/014ba53e-d2d8-4cf9-9b1f-ae5074083865

> Inspection records and compliance data for Apotex Inc. in North York, None. Access full analysis and detailed observations.

---

## Details

- Name: Apotex Inc.
- FEI Number: 3002906944
- Canada Business Number: 897397931
- City: North York
- State: None
- Country Name: Canada
- Address Line 1: 150 Signet Dr
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [Canada Inspection - Apotex Inc. - Inspection #88798 - 2026-04-21](https://www.globalkeysolutions.net/records/canada_inspection/apotex-inc/e1b17e9d-f96f-43ca-b932-0073472c1058) — source: Canada, date: April 21, 2026
- [Canada Inspection - Apotex Inc. - Inspection #87808 - 2025-11-10](https://www.globalkeysolutions.net/records/canada_inspection/apotex-inc/bab357df-e70a-42b2-b262-c50ea7e99189) — source: Canada, date: November 10, 2025
- [Canada Inspection - Apotex Inc. - Inspection #87807 - 2025-11-10](https://www.globalkeysolutions.net/records/canada_inspection/apotex-inc/1d87218d-4980-4346-9d5d-137fdc90a7cd) — source: Canada, date: November 10, 2025
- [Canada Inspection - Apotex Inc. - Inspection #87805 - 2025-11-10](https://www.globalkeysolutions.net/records/canada_inspection/apotex-inc/5a6da120-3b3c-4cce-b89f-01357769a6de) — source: Canada, date: November 10, 2025
- [FDA Inspection 1269753 - Apotex Inc. - 2025-07-31](https://www.globalkeysolutions.net/records/fda_inspections/apotex-inc/97a6f469-c215-4e98-989c-8fcd9419767a) — source: FDA, date: July 31, 2025
- [FDA Inspection 1269753 - Apotex Inc. - 2025-07-31](https://www.globalkeysolutions.net/records/fda_inspections/apotex-inc/57bde052-03fc-40c8-847d-4328a318e47b) — classification: No Action Indicated (NAI), source: FDA, date: July 31, 2025
- [WARNING_LETTER - Apotex Inc. - 2025-05-09](https://www.globalkeysolutions.net/records/warning_letter/apotex-inc/daf6e345-421a-46ae-a404-4e7687d65d58) — source: FDA, date: May 9, 2025
- [Canada Inspection - Apotex Inc. - Inspection #86458 - 2025-04-14](https://www.globalkeysolutions.net/records/canada_inspection/apotex-inc/4074093e-bf9f-4c3f-ba31-dafad9db4cf9) — source: Canada, date: April 14, 2025
- [Canada Inspection - Apotex Inc. - Inspection #82331 - 2023-12-05](https://www.globalkeysolutions.net/records/canada_inspection/apotex-inc/6a117081-22ea-457e-a0ed-69c5b250599e) — source: Canada, date: December 5, 2023
- [Canada Inspection - Apotex Inc. - Inspection #81912 - 2023-10-16](https://www.globalkeysolutions.net/records/canada_inspection/apotex-inc/eadf3292-514d-4e17-a8d9-43b1dfc014a0) — source: Canada, date: October 16, 2023
- [Canada Inspection - Apotex Inc. - Inspection #80414 - 2023-02-14](https://www.globalkeysolutions.net/records/canada_inspection/apotex-inc/6b88b3dd-6ed6-4e28-8260-aecf43a6dfd4) — source: Canada, date: February 14, 2023
- [Canada Inspection - Apotex Inc. - Inspection #80413 - 2023-02-14](https://www.globalkeysolutions.net/records/canada_inspection/apotex-inc/c42b29a9-4447-47cb-b6e6-fd53d126e01c) — source: Canada, date: February 14, 2023
- [Canada Inspection - Apotex Inc. - Inspection #80165 - 2023-01-16](https://www.globalkeysolutions.net/records/canada_inspection/apotex-inc/d29330f8-83fa-4819-97cb-391af73474b9) — source: Canada, date: January 16, 2023
- [FDA Inspection 1187415 - Apotex Inc. - 2022-09-23](https://www.globalkeysolutions.net/records/fda_inspections/apotex-inc/165e170e-ceda-479d-af49-04af908c89f0) — classification: No Action Indicated (NAI), source: FDA, date: September 23, 2022
- [FDA Inspection 1096465 - Apotex Inc. - 2019-06-19](https://www.globalkeysolutions.net/records/fda_inspections/apotex-inc/ed904b8d-eb59-4fe1-a5a8-7cc66e9c7e02) — classification: No Action Indicated (NAI), source: FDA, date: June 19, 2019
- [FDA Inspection 1055197 - Apotex Inc. - 2018-05-10](https://www.globalkeysolutions.net/records/fda_inspections/apotex-inc/71cde42d-9f01-4c81-a7fa-462e94b2420a) — classification: No Action Indicated (NAI), source: FDA, date: May 10, 2018
- [FDA Inspection 1014399 - Apotex Inc. - 2017-06-14](https://www.globalkeysolutions.net/records/fda_inspections/apotex-inc/b73018e8-e186-42c5-8fc6-27ed8d2b5296) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 14, 2017
- [FDA Inspection 927965 - Apotex Inc. - 2015-05-11](https://www.globalkeysolutions.net/records/fda_inspections/apotex-inc/22d79bd0-7ecd-4663-9df9-cec24dd0c2b0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 11, 2015
- [FDA Inspection 852610 - Apotex Inc. - 2013-08-20](https://www.globalkeysolutions.net/records/fda_inspections/apotex-inc/0472e78b-fc36-4146-bb6f-3e778de47ca7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 20, 2013
- [FDA Inspection 799252 - Apotex Inc. - 2012-08-24](https://www.globalkeysolutions.net/records/fda_inspections/apotex-inc/1266baa9-e825-4b5c-b6d8-b09a08c1a663) — classification: Official Action Indicated (OAI), source: FDA, date: August 24, 2012

## Related Companies

- [Genvion Corporation](https://www.globalkeysolutions.net/companies/genvion-corporation/a4655b0c-e1a8-4645-bd02-3bcb514a08ce)
- [Omega Laboratories Ltd.](https://www.globalkeysolutions.net/companies/omega-laboratories-ltd/79ded706-b117-405b-bd4c-4d672692c341)
- [Juno Pharma Canada Inc.](https://www.globalkeysolutions.net/companies/juno-pharma-canada-inc/5357e11b-5224-455b-a6b2-ea4095a8e378)
- [Pfizer Canada ULC](https://www.globalkeysolutions.net/companies/pfizer-canada-ulc/3beee662-1fd4-4595-9b26-69e120767b2e)
- [Sterinova Inc](https://www.globalkeysolutions.net/companies/sterinova-inc/d835f3d3-5108-4299-a6f9-f3bd7d909636)
- [Neuland Laboratories Limited](https://www.globalkeysolutions.net/companies/neuland-laboratories-limited/12a5f8b1-796d-4ef9-8ca2-08c00828593f)
- [MSN Laboratories Private Limited](https://www.globalkeysolutions.net/companies/msn-laboratories-private-limited/72db36dd-758e-4fe6-a530-188192d021c9)
- [Hetero Labs Limited](https://www.globalkeysolutions.net/companies/hetero-labs-limited/86d0caa8-c423-4eb1-b726-2ee91f560402)
- [Harman Finochem Ltd](https://www.globalkeysolutions.net/companies/harman-finochem-ltd/baee2081-28d8-4273-83c1-951887c42275)
- [PolyPeptide Laboratories France](https://www.globalkeysolutions.net/companies/polypeptide-laboratories-france/ba364871-680d-42b9-b6e0-58178c05a980)

## Related Officers

- [Director](https://www.globalkeysolutions.net/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)